Based on the provided data, cbdMD Inc (YCBD) does not present a compelling buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading signals, and neutral sentiment from hedge funds and insiders suggest a 'hold' decision at this time.
The MACD is positive and expanding (0.00959), indicating a mild bullish trend. RSI is neutral at 54.912, and moving averages are converging, suggesting no strong directional momentum. Key support is at 0.653, and resistance is at 0.769. Pre-market price is 0.7399, down -0.95%.
The MACD indicates a mild bullish trend, and there is a 70% chance of a 3.59% increase in the next day based on historical patterns.
Revenue, Net Income, EPS, and Gross Margin have all declined significantly YoY in the latest quarter (2026/Q1). No significant hedge fund or insider trading activity. No recent news or congress trading data available.
In 2026/Q1, revenue dropped to $5,016,904 (-1.89% YoY), net income fell to -$324,602 (-67.06% YoY), EPS declined to -0.04 (-97.69% YoY), and gross margin decreased to 54.93% (-9.48% YoY).
No analyst rating or price target data provided.